Is Neil Woodford taking a huge risk with his Income Focus Fund portfolio?

Paul Summers take a look at which companies have made it into the star fund manager’s new dividend-focused fund.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Yesterday afternoon, star fund manager Neil Woodford revealed which stocks had been selected for his new Income Focus Fund. While some names are no surprise, others are likely to raise more than a few eyebrows. Let’s take a look at a sample of those which have made the grade and ask: has the UK’s most trusted professional investor’s need to offer sizeable returns forced him to take on too much risk?

A few old favourites 

Taking up over 7% of the portfolio, pharmaceuticals giant Astrazeneca remains a firm favourite with the former Invesco man. No doubt Woodford will be buoyed by the positive outcome from recent trials of its Infinzi lung cancer drug.

Legal & General and tobacco giant Imperial Brands take up the second and third slots in the portfolio. With respective yields of just under 6% and 4.6% for the current year, that’s to be expected. Further down, 5.7%-yielding Lloyds Bank also makes an appearance.

While not a part of his hugely popular Equity Income fund, it’s easy to see why Woodford has also opted to include Aviva as a significant holding in the Income Focus portfolio. Under the stewardship of CEO Mark Wilson, the £22bn cap insurer has been hiking dividends at a rapid pace over the last few years.

More risk, less reward?

Other selections may be more controversial, however. Indeed, thanks to the need to generate substantial dividends, it seems Woodford has become more contrarian than ever before.

Take the inclusion of utility behemoth SSE. Yesterday’s announcement that dividend cover would be “within, but towards the bottom range of around 1.2 to 1.4 times ” wasn’t particularly reassuring. Theresa May’s proposal to introduce a price cap on standard variable tariffs if elected is hardly good news either.

Clothing retailer Next, is another curious selection, particularly as the FTSE 100 giant’s high street stores are continuing to struggle as more consumers migrate online. Representing 2% of the fund portfolio, Woodford clearly believes these concerns have been overdone.

Debt-ridden breakdown specialist AA, and troubled outsourcer Capita also make the cut, despite the latter experiencing a truly awful 2016.

Elsewhere, some may consider the inclusion of housebuilders within the portfolio as risky considering that the full impact of Brexit is still unknown. Taylor Wimpey, Barratt Developments, Crest Nicholson and Bovis Homes all make an appearance. According to Woodford however, “people are too downbeat about the UK economy,” leaving these stocks trading on “depressed valuations.” Let’s hope he’s right.

Safety in diversity?

To generate superior results from investing — be it in the form of capital gains or dividends — means doing things that many investors wouldn’t, in the hope it doesn’t backfire. To achieve the 5% yield targeted by the fund, that’s exactly what Neil Woodford is required to do. Time will tell as to whether his optimistic outlook on certain constituents was justified.

That said, one of the attractions of investing in funds such as Income Focus is the instant diversification on offer. A less concentrated basket of shares like this might prevent investors from making life-changing gains immediately, but it also offers a degree of security should one, two or several be forced to revise their dividend policies.

So, while I don’t necessarily share Woodford’s confidence on every selection, the wide spread of companies from different markets and industries should allow those invested to sleep at night.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Paul Summers has no position in any shares mentioned. The Motley Fool UK has recommended AstraZeneca, Imperial Brands, and Lloyds Banking Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Person holding magnifying glass over important document, reading the small print
Investing Articles

Just released: our top 3 small-cap stocks to consider buying in October [PREMIUM PICKS]

Small-cap shares tend to be more volatile than larger companies, so we suggest investors should look to build up a…

Read more »

Investing Articles

How I’d use an empty Stocks and Shares ISA to aim for a £1,000 monthly passive income

Here's how using a Stocks and Shares ISA really could help those of us who plan to invest for an…

Read more »

Investing Articles

This FTSE stock is up 20% and set for its best day ever! Time to buy?

This Fool takes a look at the half-year results from Burberry (LON:BRBY) to see if the struggling FTSE stock might…

Read more »

Investing Articles

This latest FTSE 100 dip could be an unmissable opportunity to pick up cut-price stocks

The FTSE 100 has pulled back with the government’s policy choices creating some negative sentiment. But this gives us a…

Read more »

A young woman sitting on a couch looking at a book in a quiet library space.
Investing Articles

As the WH Smith share price falls 4% on annual results, is it still worth considering?

WH Smith took a hit after this morning’s results left shareholders unimpressed. With the share price down 4%, Mark Hartley…

Read more »

Investing Articles

The Aviva share price just jumped 4.5% but still yields 7.02%! Time to buy?

A positive set of results has put fresh life into the Aviva share price. Harvey Jones says it offers bags…

Read more »

Investing Articles

Can a €500m buyback kickstart the Vodafone share price?

The Vodafone share price has been a loser for investors in recent years, and the dividend has been cut. We…

Read more »

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Growth Shares

3 mistakes I now avoid when choosing which growth stocks to buy

Jon Smith runs through some of the lessons he's learnt the hard way over the years about what to look…

Read more »